Nicotinell Mint

Nicotine, the active ingredient in Nicotinell Mint, is a nicotinic receptor agonist presented as a nicotine‑containing oromucosal product for oromucosal use. It treats nicotine dependence and aids smoking cessation in adult smokers.

GNH USA supplies Nicotinell Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine is used in smoking cessation therapy to reduce nicotine withdrawal symptoms.

- Smoking cessation: helps adult smokers reduce cravings and quit smoking. - Tobacco dependence: assists individuals dependent on tobacco to manage withdrawal. - Relapse prevention: supports former smokers in maintaining abstinence.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat irritation: discomfort or scratchy sensation. - Nausea: occasional feeling of queasiness. - Hiccups: transient involuntary diaphragm spasms. - Dizziness: light‑headed sensation. - Headache: mild to moderate pain.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Cardiovascular events: increased heart rate or blood pressure. - Severe mouth ulceration: painful lesions in the oral mucosa. - Persistent vomiting: ongoing nausea and vomiting. - Syncope: fainting episodes.

Before using Nicotinell Mint, consider the following precautions: - Cardiovascular assessment: evaluate heart conditions as nicotine may affect heart rate. - Use as directed: follow prescriber instructions regarding frequency and duration. - Non‑smoker avoidance: do not use if you are not a regular smoker. - Child safety: keep product out of reach of children to prevent accidental ingestion. - Storage: Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Nicotine may interact with other substances; monitor the following:

Major Interactions (Avoid): - Concurrent nicotine replacement therapy: risk of nicotine overdose. - Monoamine oxidase inhibitors: may increase cardiovascular side effects.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors: can alter nicotine metabolism, affecting plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Antidepressants (SSRIs): may enhance nicotine‑related mood changes.